Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development
about
Antifungal Therapy: New Advances in the Understanding and Treatment of MycosisInhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilmUse of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins.Invasive candidiasis serological diagnosis in solid organ transplant recipients.Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based IdentificationOverexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro studyβ-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.Antifungal and antiviral products of marine organisms.Antifungal activity of dual combination of hydroxychavicol with commercialized agents against oral Candida species.Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicansAn in Vitro Study on the Effect of Combined Treatment with Photodynamic and Chemical Therapies on Candida albicans.Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.Functions of cell wall glycosidases and in biofilm formation and HOG MAPK pathway
P2860
Q28818603-7B201121-C2D4-45A6-A6DA-98FAFF770E6CQ35076919-2A5B764E-BCDA-463B-8316-CB212CEA7311Q35619432-903EC222-87BE-4BBA-B860-B025C5EB632FQ35631863-62EEF0EC-3F8F-4E10-9698-E12FA5EE971FQ35752374-317411AD-FB9E-4E02-AC03-FFD26FB37F42Q35756098-56B50F0B-EF14-4F13-ABBA-12CB35978140Q35851241-5FA10072-E92E-4B74-9EDE-B51C85A1E3D9Q37546944-9D7FA0BD-A060-4BAC-8652-19F156B6B927Q37634178-08AC7E40-5CC1-487D-B6C8-90306E247DE8Q39273596-75C4FDFE-C65B-4F69-8492-401AAC8CDE40Q41561738-9C8A6B11-63CD-47F4-94FD-2FFEBB0A3DB9Q48175808-7E1E4240-B761-44C1-87F0-CBCCFBCCFFE6Q53622505-F3CC47AD-EA54-4EAB-9702-941DB2300A45Q57067518-2F04C7D1-A3CE-4952-A39D-892BD3C63369
P2860
Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifungal agents commonly use ...... ion and resistance development
@en
Antifungal agents commonly use ...... on and resistance development.
@nl
type
label
Antifungal agents commonly use ...... ion and resistance development
@en
Antifungal agents commonly use ...... on and resistance development.
@nl
prefLabel
Antifungal agents commonly use ...... ion and resistance development
@en
Antifungal agents commonly use ...... on and resistance development.
@nl
P2860
P356
P1476
Antifungal agents commonly use ...... ion and resistance development
@en
P2093
Małgorzata Bondaryk
Wiesław Kurzątkowski
P2860
P304
P356
10.5114/PDIA.2013.38358
P577
2013-10-30T00:00:00Z